The contractors and the city failed to implement an effective system for deterring such a threat, the suit said.

Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into Phase 2 testing for idiopathic pulmonary fibrosis. Mediar said it expects to ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Juan M. Morales Juan M. Morales, a devoted husband, father, grandfather, and friend, peacefully passed away at home on Dec. 31, 2024, at the age of 87, ...

Eli Lilly in talks to acquire cancer biotech Scorpion Therapeutics for $2.5 billion, with potential milestone payments.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Not only was the role transformative for the singer and actress, but on set of Wicked, she met her boyfriend, Ethan Slater, ...

FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.

Influencer Lilly-Ella Gerrard is expecting her first child with the son of a notorious Irish gangster, whose brother was ...

The 2025 roster of 18 gymnasts features 12 returners and six true freshmen (Love Birt, Brooke Dennis, Ryan Fuller, Kylee ...

Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.